Popular weight-loss drugs, especially tirzepatide, are linked to modestly lower CPAP initiation among adults with Type 2 diabetes and obstructive sleep apnea (OSA), according to a research letter in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback